Page last updated: 2024-10-29

ifosfamide and Sarcoma, Endometrial Stromal

ifosfamide has been researched along with Sarcoma, Endometrial Stromal in 5 studies

Sarcoma, Endometrial Stromal: A highly malignant subset of neoplasms arising from the endometrial stroma. Tumors in this group infiltrate the stroma with a wide range of atypia cells and numerous mitoses. They are capable of widespread metastases (NEOPLASM METASTASIS).

Research Excerpts

ExcerptRelevanceReference
"To determine the effectiveness and toxicity of ifosfamide chemotherapy in women with metastatic or recurrent endometrial stromal sarcomas unexposed to other chemotherapy."9.08Ifosfamide treatment of recurrent or metastatic endometrial stromal sarcomas previously unexposed to chemotherapy: a study of the Gynecologic Oncology Group. ( Blessing, JA; DiSaia, PJ; Park, R; Rosenshein, N; Sutton, G, 1996)
"To determine the effectiveness and toxicity of ifosfamide chemotherapy in women with metastatic or recurrent endometrial stromal sarcomas unexposed to other chemotherapy."5.08Ifosfamide treatment of recurrent or metastatic endometrial stromal sarcomas previously unexposed to chemotherapy: a study of the Gynecologic Oncology Group. ( Blessing, JA; DiSaia, PJ; Park, R; Rosenshein, N; Sutton, G, 1996)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Inoue, S1
Hirai, S1
Katayama, T1
Miolo, G1
Viel, A1
Canzonieri, V1
Baresic, T1
Buonadonna, A1
Santeufemia, DA1
Lara, DP1
Corona, G1
Ushijima, M1
Yamakawa, Y1
Sakabe, E1
Waki, H1
Katou, K1
Sutton, G1
Blessing, JA1
Park, R1
DiSaia, PJ1
Rosenshein, N1
Yamawaki, T1
Shimizu, Y1
Hasumi, K1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Endometrial Stromal Tumors: an Observational Study[NCT02829437]100 participants (Anticipated)Observational2016-10-31Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for ifosfamide and Sarcoma, Endometrial Stromal

ArticleYear
Ifosfamide treatment of recurrent or metastatic endometrial stromal sarcomas previously unexposed to chemotherapy: a study of the Gynecologic Oncology Group.
    Obstetrics and gynecology, 1996, Volume: 87, Issue:5 Pt 1

    Topics: Antineoplastic Agents, Alkylating; Drug Administration Schedule; Endometrial Neoplasms; Female; Huma

1996

Other Studies

4 other studies available for ifosfamide and Sarcoma, Endometrial Stromal

ArticleYear
[Lung Metastasis from High-grade Uterine Endometrial Stromal Sarcoma;Report of a Case].
    Kyobu geka. The Japanese journal of thoracic surgery, 2020, Volume: 73, Issue:8

    Topics: Aged; Endometrial Neoplasms; Female; Heparin; Humans; Ifosfamide; Lung Neoplasms; Sarcoma, Endometri

2020
Association of the germline BRCA2 missense variation Glu2663Lys with high sensitivity to trabectedin-based treatment in soft tissue sarcoma.
    Cancer biology & therapy, 2016, 10-02, Volume: 17, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Bone Neoplasms; BRCA2 Protein; Dioxol

2016
[A case of recurrent high-grade endometrial stromal sarcoma controlled by a combination of Ifosfamide, adriamycin, and cisplatin].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:10

    Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Endomet

2010
Treatment of stage IV "high-grade" endometrial stromal sarcoma with ifosfamide, adriamycin, and cisplatin.
    Gynecologic oncology, 1997, Volume: 64, Issue:2

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxoru

1997